Literature DB >> 33458612

The importance of glycogen molecular structure for blood glucose control.

Asad Nawaz1,2, Peng Zhang3, Enpeng Li1,2, Robert G Gilbert1,2,4, Mitchell A Sullivan5.   

Abstract

Type 2 diabetes incidence continues to increase rapidly. This disease is characterized by a breakdown in blood glucose homeostasis. The impairment of glycemic control is linked to the structure of glycogen, a highly branched glucose polymer. Liver glycogen, a major controller of blood sugar, comprises small β particles which can link together to form larger α particles. These degrade to glucose more slowly than β particles, enabling a controlled release of blood glucose. The α particles in diabetic mice are however easily broken down into β particles, which degrade more quickly. Because this may lead to higher blood glucose, understanding this diabetes-associated breakdown of α-particle molecular structure may help in the development of diabetes therapeutics. We review the extraction of liver glycogen, its molecular structure, and how this structure is affected by diabetes and then use this knowledge to make postulates to guide the development of strategies to help mitigate type 2 diabetes.
© 2020 The Authors.

Entities:  

Keywords:  Diabetology; Glycobiology; Molecular Structure

Year:  2020        PMID: 33458612      PMCID: PMC7797522          DOI: 10.1016/j.isci.2020.101953

Source DB:  PubMed          Journal:  iScience        ISSN: 2589-0042


  50 in total

1.  Autoimmune type 1 diabetes: resolved and unresolved issues.

Authors:  A L Notkins; A Lernmark
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Control of phosphorylase activity in a muscle glycogen particle. I. Isolation and characterization of the protein-glycogen complex.

Authors:  F Meyer; L M Heilmeyer; R H Haschke; E H Fischer
Journal:  J Biol Chem       Date:  1970-12-25       Impact factor: 5.157

3.  A precursor of glycogen biosynthesis: alpha-1,4-glucan-protein.

Authors:  C R Krisman; R Barengo
Journal:  Eur J Biochem       Date:  1975-03-03

4.  Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Authors:  Pouya Saeedi; Inga Petersohn; Paraskevi Salpea; Belma Malanda; Suvi Karuranga; Nigel Unwin; Stephen Colagiuri; Leonor Guariguata; Ayesha A Motala; Katherine Ogurtsova; Jonathan E Shaw; Dominic Bright; Rhys Williams
Journal:  Diabetes Res Clin Pract       Date:  2019-09-10       Impact factor: 5.602

5.  AMP-activated protein kinase does not associate with glycogen alpha-particles from rat liver.

Authors:  Glendon J Parker; Ann Koay; Ryan Gilbert-Wilson; Lynne J Waddington; David Stapleton
Journal:  Biochem Biophys Res Commun       Date:  2007-08-24       Impact factor: 3.575

6.  Characterization of glycogen molecular structure in the worm Caenorhabditis elegans.

Authors:  Qinghua Liu; Zuobin Zhu; Mengmeng Wang; Yuechen Wang; Peng Zhang; Hao Wang; Mengyu Liang; Ying Li; Bin Deng; Daoquan Tang; Robert G Gilbert; Liang Wang
Journal:  Carbohydr Polym       Date:  2020-03-17       Impact factor: 9.381

7.  Analysis of starch structure using fluorophore-assisted carbohydrate electrophoresis.

Authors:  M K Morell; M S Samuel; M G O'Shea
Journal:  Electrophoresis       Date:  1998-11       Impact factor: 3.535

8.  Aberrations in the diurnal rhythms of plasma glucose, plasma insulin, liver glycogen, and hepatic glycogen synthase and phosphorylase activities in genetically diabetic (db/db) mice.

Authors:  W J Roesler; C Helgason; M Gulka; R L Khandelwal
Journal:  Horm Metab Res       Date:  1985-11       Impact factor: 2.936

Review 9.  Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan.

Authors:  Mitchell A Sullivan; Silvia Nitschke; Martin Steup; Berge A Minassian; Felix Nitschke
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

10.  Proteomic Investigation of the Binding Agent between Liver Glycogen β Particles.

Authors:  Xinle Tan; Mitchell A Sullivan; Sharif S Nada; Bin Deng; Benjamin L Schulz; Robert G Gilbert
Journal:  ACS Omega       Date:  2018-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.